VOYA Investment Management
SCPH

VOYA Investment Management’s scPharmaceuticals SCPH Stock Holding History

VOYA Investment Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,954
Closed -$41.7K – 2620
2025
Q2 		$41.7K Buy
+10,954
New +$34K ﹤0.01% 2625
2024
Q4 		– Sell
-11,389
Closed -$51.9K – 2789
2024
Q3 		$51.9K Sell
11,389
-112
-1% -$542 ﹤0.01% 2769
2024
Q2 		$50K Buy
+11,501
New +$50.5K ﹤0.01% 2793
2024
Q1 		– Sell
-11,752
Closed -$73.7K – 2868
2023
Q4 		$73.7K Hold
11,752
– – ﹤0.01% 2805
2023
Q3 		$83.7K Hold
11,752
– – ﹤0.01% 2773
2023
Q2 		$120K Buy
+11,752
New +$123K ﹤0.01% 2736

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $168B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return